Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: A retrospective cohort study

The expansion of antiretroviral therapy (ART) eligibility could lead to earlier initiation of Human Immunodefciency Virus (HIV) treatment and consequently reduce the risk of HIV-associated Kaposi Sarcoma (KS). We investigated the impact of changes in the Nigerian HIV treatment guidelines on KS incidence among adults enrolled in HIV care in Nigeria.